BE905255A - Dispositif de distribution a debit controle pour l'administration d'un agent benefique. - Google Patents

Dispositif de distribution a debit controle pour l'administration d'un agent benefique.

Info

Publication number
BE905255A
BE905255A BE0/217033A BE217033A BE905255A BE 905255 A BE905255 A BE 905255A BE 0/217033 A BE0/217033 A BE 0/217033A BE 217033 A BE217033 A BE 217033A BE 905255 A BE905255 A BE 905255A
Authority
BE
Belgium
Prior art keywords
beneficial agent
distribution device
delivery
flow rate
controlled flow
Prior art date
Application number
BE0/217033A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BE905255A publication Critical patent/BE905255A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • External Artificial Organs (AREA)

Abstract

Dispositif de distribution d'un agent bénéfique, comprenant (1) un logement définissant un espace interne (2) une compositon thermosensible contenant un agent bénéfique dans cet espace, (3) un solute osmotiquement efficace dans cet espace et (4) au moins une voie de passage dans le logement pour débiter l'agent bénéfique depuis ce dispositif de distribution.
BE0/217033A 1985-08-08 1986-08-08 Dispositif de distribution a debit controle pour l'administration d'un agent benefique. BE905255A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/763,493 US4684524A (en) 1984-03-19 1985-08-08 Rate controlled dispenser for administering beneficial agent

Publications (1)

Publication Number Publication Date
BE905255A true BE905255A (fr) 1986-12-01

Family

ID=25067977

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/217033A BE905255A (fr) 1985-08-08 1986-08-08 Dispositif de distribution a debit controle pour l'administration d'un agent benefique.

Country Status (14)

Country Link
US (1) US4684524A (fr)
JP (1) JPH0759497B2 (fr)
AU (3) AU590308B2 (fr)
BE (1) BE905255A (fr)
BR (1) BR8603756A (fr)
CA (1) CA1265966A (fr)
DE (1) DE3626103C2 (fr)
ES (1) ES8802113A1 (fr)
FR (1) FR2585951B1 (fr)
GB (1) GB2178660B (fr)
IT (1) IT1195819B (fr)
NL (1) NL8601981A (fr)
NZ (1) NZ217024A (fr)
ZA (1) ZA865982B (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948769A (en) * 1984-01-28 1999-09-07 Ismail; Roshdy Agent for treating heart diseases
DE3582439D1 (de) * 1984-01-28 1991-05-16 Roshdy Ismail Mittel zur behandlung von herzerkrankungen.
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4814180A (en) * 1984-03-21 1989-03-21 Alza Corporation Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
GB8717168D0 (en) * 1987-07-21 1987-08-26 Roussel Lab Ltd Controlled-release device
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
JP2835051B2 (ja) * 1988-07-06 1998-12-14 オリンパス光学工業株式会社 医療用カプセル
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
US5342624A (en) * 1989-02-16 1994-08-30 British Technology Group Ltd. Dispensing device
US5372776A (en) * 1989-04-07 1994-12-13 Alza Corporation Density element and method of manufacture thereof to achieve a particular transverse rupture strength
US5206024A (en) * 1989-04-07 1993-04-27 Alza Corporation Density element for ruminal delivery device
US5417976A (en) * 1989-04-07 1995-05-23 Alza Density element and method of manufacture thereof
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
US5474785A (en) * 1990-01-24 1995-12-12 Alza Corporation Delivery system comprising means for controlling internal pressure
US5223266A (en) * 1990-01-24 1993-06-29 Alza Corporation Long-term delivery device with early startup
US5156623A (en) * 1990-04-16 1992-10-20 Olympus Optical Co., Ltd. Sustained release material and method of manufacturing the same
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
FI923023A7 (fi) * 1990-10-31 1992-06-29 Baxter Int Lähellään tapahtuvan verisuonittumisen aikaansaava istutemateriaali
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JP3722832B2 (ja) * 1992-06-22 2005-11-30 ルーナー、コーポレーション 経口用１α−ヒドロキシプレビタミンＤ
US5609885A (en) * 1992-09-15 1997-03-11 Alza Corporation Osmotic membrane and delivery device
US6191105B1 (en) 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
US5681811A (en) * 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
AU697044B2 (en) * 1993-06-14 1998-09-24 Emisphere Technologies, Inc. Proteinoid carriers
US5651976A (en) * 1993-06-17 1997-07-29 The United States Of America As Represented By The Secretary Of The Navy Controlled release of active agents using inorganic tubules
JPH08503715A (ja) * 1993-09-24 1996-04-23 バクスター、インターナショナル、インコーポレイテッド 埋め込み装置の血管化を促進するための方法
US6156305A (en) * 1994-07-08 2000-12-05 Baxter International Inc. Implanted tumor cells for the prevention and treatment of cancer
US5607696A (en) * 1995-02-10 1997-03-04 Alza Corporation Osmotic membrane and delivery device
US6395292B2 (en) * 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6703381B1 (en) 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
AU2003236521A1 (en) * 2002-06-13 2003-12-31 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
EP1596767B1 (fr) 2003-02-12 2018-10-03 Syncera, Inc. Compositions a base d'alliages de polymeres d'oxyde d'alkylene aleatoires et non aleatoires
RU2527893C2 (ru) 2004-07-19 2014-09-10 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
CA2624897C (fr) * 2005-10-12 2017-02-14 Proventiv Therapeutics, Llc Procedes et articles servant a traiter l'insuffisance et la deficience en 25-hydroxyvitamine d
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US11752158B2 (en) * 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
US8592401B2 (en) * 2007-04-25 2013-11-26 Proventiv Therapeutics, Llc Methods and compounds for vitamin D therapy
HUE073014T2 (hu) 2007-04-25 2025-12-28 Opko Renal Llc Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US20130079749A1 (en) * 2007-08-29 2013-03-28 Advanced Bionics, Llc Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
RU2453332C2 (ru) 2007-10-16 2012-06-20 Байокон Лимитид Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
EP2281058B1 (fr) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Procédés, compositions, utilisations, et kits utiles pour la carence en vitamine d et des troubles associés
BR112012002271B1 (pt) 2009-07-31 2020-06-16 Merial, Inc Cápsulas de liberação sustentada
WO2011123476A1 (fr) 2010-03-29 2011-10-06 Cytochroma Inc. Procédés et compositions pour réduction de taux d'hormone parathyroïde
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
EP4208157A1 (fr) 2020-09-04 2023-07-12 Elanco Us Inc. Formulations palatables

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2340037A (en) * 1941-09-08 1944-01-25 Zipper Alfred Irving Capsule
FR1540258A (fr) * 1964-11-30 1968-09-27 Magnesium Elektron Ltd Pastilles pour ruminants comportant un corps creux en magnésium ou alliage de magnésium
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3760804A (en) * 1971-01-13 1973-09-25 Alza Corp Improved osmotic dispenser employing magnesium sulphate and magnesium chloride
US4034756A (en) * 1971-01-13 1977-07-12 Alza Corporation Osmotically driven fluid dispenser
US3732865A (en) * 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3769895A (en) * 1971-06-09 1973-11-06 Teletype Corp Masking for printed circuit photomasters
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3929132A (en) * 1973-04-10 1975-12-30 Alza Corp Osmotic dispenser
US3995632A (en) * 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
DE2729068A1 (de) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
US4196187A (en) * 1977-09-02 1980-04-01 Eastman Kodak Company Rumen-stable pellets
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US4595583A (en) * 1984-03-19 1986-06-17 Alza Corporation Delivery system controlled administration of beneficial agent to ruminants
FR2565102B1 (fr) * 1984-06-05 1987-03-20 Paris Sud Universite Microcapsules biodegradables a base de serumalbumine, leur preparation et leur application a la liberation in situ de medicuments
JPH0641406A (ja) * 1992-07-23 1994-02-15 Teijin Ltd 難燃性ポリエステル樹脂組成物

Also Published As

Publication number Publication date
FR2585951A1 (fr) 1987-02-13
AU590308B2 (en) 1989-11-02
AU654515B2 (en) 1994-11-10
JPH0759497B2 (ja) 1995-06-28
GB2178660A (en) 1987-02-18
NL8601981A (nl) 1987-03-02
IT1195819B (it) 1988-10-27
ES8802113A1 (es) 1988-04-01
US4684524A (en) 1987-08-04
AU8788691A (en) 1992-01-16
AU8973891A (en) 1992-02-13
IT8667646A0 (it) 1986-08-08
GB2178660B (en) 1989-09-06
AU6078086A (en) 1987-02-12
NZ217024A (en) 1989-07-27
FR2585951B1 (fr) 1989-03-03
CA1265966A (fr) 1990-02-20
ES556375A0 (es) 1988-04-01
DE3626103C2 (de) 1998-02-19
ZA865982B (en) 1987-04-29
JPS6239519A (ja) 1987-02-20
GB8618568D0 (en) 1986-09-10
DE3626103A1 (de) 1987-02-12
BR8603756A (pt) 1987-03-10

Similar Documents

Publication Publication Date Title
BE905255A (fr) Dispositif de distribution a debit controle pour l'administration d'un agent benefique.
IT8719909A0 (it) Sistema e dispositivo per far erogare quantita' prefissate di liquido da una pompa dosatrice in regime di portata variabile.
BE905214A (fr) Dispositif a liberation controlee pour l'administration d'un agent benefique.
BE901941A (fr) Systeme de distribution pour l'administration controlee d'agent benefique aux ruminants.
ATE90000T1 (de) System zur parenteralen verabreichung eines wirkstoffs.
DE69510054D1 (de) Osmotisch wirkendes system zur abgabe von flüssigkeitssensitivem somatotropin in rindern
ES275021U (es) Un dispositivo mejorado para la administracion de medicamentos a un paciente por via parenteral.
ATE369158T1 (de) Arzneimittelsteuerung durch strömungsumleitung
EP0376935A3 (en) Irrigation appliance
FR2435615A1 (fr) Pompe destinee notamment a des applications medicales
ES2156585T3 (es) Sistema de administracion por via intravenosa.
MA22679A1 (fr) Dispositif pour delivrer de facon pulsee un liquide d'irrigation et systemes d'irrigation qui incorporent ce dispositif.
FR2632306B1 (fr) Forme posologique pour delivrer a un debit regle un antiangineux
SE9200287D0 (sv) Utportioneringsanordning
BE901530A (fr) Ajutages d'atomiseur.
FR2713216B1 (fr) Dispositif pour délivrer, à cadence élevée, des doses d'un liquide.
DE69321734D1 (de) Infusionsbeutel mit zwei kammern
FR2690623B1 (fr) Dispositif de contrôle de débit pour systèmes de perfusion.
CH532245A (fr) Dispositif pour la fourniture répétée de volumes de fluide réglables avec précision, comprenant au moins une pompe doseuse à débit variable
ATE133069T1 (de) Verabreichungssystem mit mitteln zur kontrolle des internen druckes
FR2565709B1 (fr) Dispositif de reglage du debit d'un liquide dans une conduite, notamment d'un liquide de refroidissement
BE899837A (fr) Dispositif pour chauffer des tablettes impregnees de substances evaporables.
IT8741705A0 (it) Regolo per il calcolo istantaneo della velocita'di deflusso di una qualsiasi soluzione conoscendo la quantita'di soluto da infondere nell'unita'di tempo il volume di diliuzione e la quantita'di soluto in esso diluita.
ITMI921320A0 (it) Dispositivo di regolazione di flusso per dispensatori di fluido, in particolare per fleboclisi
EP0058292A3 (fr) Appareil pour délivrer dans un laps de temps une quantité prédéterminée d'un produit liquide à usage thérapeutique

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ALZA CORP.

Effective date: 20060808